Stroke Dx
Culver City, US · 8 employees on LinkedIn · 2 known investors
Find your way into Stroke Dx
154 people in our graph share verified history with the Stroke Dx team — schools, employers, funds. One of them is your warm intro.
Melody Maunlockedknows Shane Shahrestani · together at UCLA (overlapped)
×6knows the team · via UCLA
×3knows the team · via Cedars-Sinai
knows the team · via Caltech
knows the team · via Keck School of Medicine of the University of Southern California
NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions. Its product is not yet FDA cleared or commercially available.
Founders & leadership
AB
Alexander BallatoriCofounder30 Under 30 2025
SS
Shane ShahrestaniinCo-FounderShane Shahrestani is a neurosurgery resident at Cedars-Sinai Medical Center and holds an MD/PhD from USC-Caltech. He is co-founder and Chief Scientific and Innovation Officer at NeuraNova, which develops non-invasive diagnostic technology for detecting stroke and brain-related conditions.30 Under 30 2025
Investors · 2
Frequently asked questions
- What does Stroke Dx do?
- NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions. Its product is not yet FDA cleared or commercially available.
- Who founded Stroke Dx?
- Stroke Dx was founded by Alexander Ballatori, Shane Shahrestani.
- Who are Stroke Dx's investors?
- Stroke Dx's investors include DigiTx Partners LLC, FREEFLOW.
- Where is Stroke Dx headquartered?
- Stroke Dx is headquartered in Culver City, US.